These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 9006094

  • 1. Increased gene specific repair of cisplatin induced interstrand crosslinks in cisplatin resistant cell lines, and studies on carrier ligand specificity.
    Petersen LN, Mamenta EL, Stevnsner T, Chaney SG, Bohr VA.
    Carcinogenesis; 1996 Dec; 17(12):2597-602. PubMed ID: 9006094
    [Abstract] [Full Text] [Related]

  • 2. Role of carrier ligand in platinum resistance in L1210 cells.
    Gibbons GR, Page JD, Mauldin SK, Husain I, Chaney SG.
    Cancer Res; 1990 Oct 15; 50(20):6497-501. PubMed ID: 2208108
    [Abstract] [Full Text] [Related]

  • 3. Role of DNA replication in carrier-ligand-specific resistance to platinum compounds in L1210 cells.
    Gibbons GR, Kaufmann WK, Chaney SG.
    Carcinogenesis; 1991 Dec 15; 12(12):2253-7. PubMed ID: 1747924
    [Abstract] [Full Text] [Related]

  • 4. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W, Chaney SG.
    Cancer Res; 1993 Feb 15; 53(4):799-805. PubMed ID: 8428361
    [Abstract] [Full Text] [Related]

  • 5. The role of DNA repair in resistance of L1210 cells to isomeric 1,2-diaminocyclohexaneplatinum complexes and ultraviolet irradiation.
    Jennerwein MM, Eastman A, Khokhar AR.
    Mutat Res; 1991 Jan 15; 254(1):89-96. PubMed ID: 1986276
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The chemistry and biology of platinum complexes with the 1,2-diaminocyclohexane carrier ligand (review).
    Chaney S.
    Int J Oncol; 1995 Jun 15; 6(6):1291-305. PubMed ID: 21556672
    [Abstract] [Full Text] [Related]

  • 8. Differential cytotoxicity, uptake and DNA binding of tetraplatin and analogous isomers in sensitive and resistant cancer cell lines.
    Kido Y, Khokhar AR, Siddik ZH.
    Anticancer Drugs; 1993 Apr 15; 4(2):251-8. PubMed ID: 8490203
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Relationship between platinum-DNA adduct formation and removal and cisplatin cytotoxicity in cisplatin-sensitive and -resistant human ovarian cancer cells.
    Johnson SW, Swiggard PA, Handel LM, Brennan JM, Godwin AK, Ozols RF, Hamilton TC.
    Cancer Res; 1994 Nov 15; 54(22):5911-6. PubMed ID: 7954422
    [Abstract] [Full Text] [Related]

  • 12. Deficient gene specific repair of cisplatin-induced lesions in Xeroderma pigmentosum and Fanconi's anemia cell lines.
    Zhen W, Evans MK, Haggerty CM, Bohr VA.
    Carcinogenesis; 1993 May 15; 14(5):919-24. PubMed ID: 8504485
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Increased gene-specific repair of cisplatin interstrand cross-links in cisplatin-resistant human ovarian cancer cell lines.
    Zhen W, Link CJ, O'Connor PM, Reed E, Parker R, Howell SB, Bohr VA.
    Mol Cell Biol; 1992 Sep 15; 12(9):3689-98. PubMed ID: 1380646
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.